POZlife

POZLife: Life from the Infected and Effected point of veiw.

HIV vaccine research hits impasse

Posted by pozlife on May 23, 2008

 

By Helen Briggs
Science reporter, BBC News, Boston

HIV binds to the surface of the human immune (CD4) cell (PRNewswire dated 19/11/07)

HIV has evolved to protect itself from the human immune system

Scientists are no further forward in developing a vaccine against HIV after more than 20 years of research, a Nobel Prize-winning biologist has said.

Professor David Baltimore, president of the American Association for the Advancement of Science (AAAS), said there was little hope among scientists.

But he said that they were continuing efforts to develop a vaccine.

“Our lack of success may be understandable but it is not acceptable,” he said.

“Some years ago I came to the conclusion that our community had to seriously undertake new approaches or we might find ourselves with a worldwide epidemic and no effective response,” Prof Baltimore told the annual meeting of the AAAS in Boston.

“That is just where we are today.”

I believe that HIV has found ways to totally fool the immune system – so we have to do one better than nature

Professor David Baltimore

Is HIV beating the scientists?

HIV had evolved a way to protect itself from the human immune system, he said.

“This is a huge challenge because to control HIV immunologically the scientific community has to beat out nature, do something that nature, with its advantage of four billion years of evolution, has not been able to do,” Prof Baltimore said.

“I believe that HIV has found ways to totally fool the immune system.

“So we have to do one better than nature.”

‘One shot’

Attempts to control the virus through antibodies or by boosting the body’s immune system have ended in failure.

This has left the vaccine community depressed because they can see no hopeful way of success, Prof Baltimore said.

Cell virus

Guide: The biology of Aids

Among the novel techniques that scientists are turning to are gene and stem cell therapy, although these are still in their infancy.

“In the human you really only have one shot which is to try to change genes in stem cells,” said Prof Baltimore, one of the leading experts on the HIV virus.

“So we’re trying to do that, to design vectors that can carry genes that will be of therapeutic advantage.”

Prof Baltimore won the Nobel Prize in Medicine in 1975 for the co-discovery of reverse transcriptase, an enzyme that was later found to be used by HIV to replicate in human cells.

He now leads the Baltimore laboratory at Caltech, with support from the Gates Foundation, to look for ways to genetically boost the immune system against infectious agents, particularly HIV.

Pie chart

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

 
%d bloggers like this: